Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SANDOZ CANDESARTAN PLUS | 25MG 32MG | TABLET | Resolved | 2023-03-27 | 2023-04-12 | 188052 |
SANDOZ CANDESARTAN PLUS | 25MG 32MG | TABLET | Resolved | 2023-06-12 | 2023-10-24 | 194757 |
SANDOZ CANDESARTAN PLUS | 25MG 32MG | TABLET | Resolved | 2023-11-20 | 2024-01-18 | 210835 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2019-01-21 | 2020-08-24 | 73123 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2019-01-21 | 2020-08-24 | 73126 |
SANDOZ CANDESARTAN PLUS | 16MG 12.5MG | TABLET | Resolved | 2020-10-05 | 2020-11-02 | 125634 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2022-11-28 | 2022-12-12 | 176046 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2023-03-06 | 2023-04-05 | 186277 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2023-06-12 | 2023-08-22 | 194754 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2023-07-24 | 2024-04-04 | 199810 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT CANDESARTAN | 4MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65171 |
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |